medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2022, Number 2

<< Back Next >>

Sal Jal 2022; 9 (2)

Prevalencia de anomalías congénitas en municipios del Estado de Jalisco durante el periodo 2015-2018

González-Landeros BM, Gutiérrez-Padilla JA, Márquez-González RM, Zalapa-Gómez MF, Sánchez-Esqueda G, González-Díaz A

Language: Spanish
References: 12
Page: 84-92
PDF size: 411.51 Kb.


ABSTRACT

Introduction: Congenital malformations (CM) are any structural or functional anomaly that occur during intrauterine life. The WHO establishes that 303,000 newborns die from this cause every year. Background: Currently there isn´t much information on the prevalence of CM in Mexico and Jalisco. Data from Secretaria de Salud de Jalisco indicates that during the period from 2015 to 2018, 29.3% of deaths of children under one year were reported due to CM, deformities and chromosomal malformations. Objectives: Crosssectional descriptive study. To describe the prevalence of CM during the years from 2015-2018 in the state of Jalisco. Method: The database from Secretaria de Salud de Jalisco from 2015-2018 was used, which includes information from 126 municipalities in the state of Jalisco. The study population was limited to fetuses and newborns with CM diagnosed during the early neonatal period. Results: A prevalence of 7,300 births with CM was reported with a distribution of 58% men and 42% female. The 10 municipalities with the highest prevalence of CM are listed, as well as the 3 most common malformations in the state of Jalisco. The city with the highest prevalence was Guadalajara and among the most frequent CM we identify the cryptorchidism, polydactyly and unspecifi ed Down syndrome. Conclusion: Creating prevention strategies that are included within our health care system will result in the reduction of cases and therefore lower neonatal, infant and even maternal mortality.


REFERENCES

  1. World Health Organization. National Center on Birth Defectsand Developmental Disabilities from the United States Centersfor Disease Control and Prevention, International Clearinghousefor Birth Defects Surveillance and Research. Birth defectssurveillance training: facilitator’s guide. Ginebra: World HealthOrganization; 2015.

  2. World Health Organization. Congenital anomalies. WorldHealth Organization, Ginebra (2020) https://www.who.int/es/news-room/fact-sheets/detail/congenital-anomalies

  3. Fernández Cantón, Sonia B, Gutiérrez Trujillo, Gonzalo, ViguriUribe, Ricardo. (2012). Principales causas de mortalidad infantilen México: tendencias recientes. Boletín médico del HospitalInfantil de México, 69(2), 144-148. Recuperado en 14 de juliode 2021, de: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462012000200011&lng=es&tlng=es.

  4. Navarrete-Hernández, E., Canún-Serrano, S., Valdés-Hernández, J., & Reyes-Pablo, A. E. (2017). Malformacionescongénitas al nacimiento: México, 2008-2013 [Congenitalmalformations at birth: Mexico, 2008-2013]. Boletin medicodel Hospital Infantil de Mexico, 74(4), 301–308. https://doi.org/10.1016/j.bmhimx.2017.02.003

  5. Navarrete-Hernández, E., Canún-Serrano, S., Valdés-Hernández, J., & Reyes-Pablo, A. E. (2020). Prevalence ofcongenital malformations and deformities of the osteomuscularsystem in live newborns in Mexico, 2008-2017. Prevalenciade malformaciones y deformidades congénitas del sistemaosteomuscular en recién nacidos vivos en México, 2008-2017.Cirugía y cirujanos, 88(3), 277–285. https://doi.org/10.24875/CIRU.20001096

  6. Hernández-Bringas, Héctor H., & Narro-Robles, José. (2019).Mortalidad infantil en México: logros y desafíos. Papeles depoblación, 25(101), 17-49. Epub 26 de junio de 2020. https://doi.org/10.22185/24487147.2019.101.22

  7. Durán, P., Liascovich, R., Barbero, P., Bidondo, M. P., Groisman,B., Serruya, S., de Francisco, L. A., Becerra-Posada, F., & Gordillo-Tobar, A. (2019). Sistemas de vigilancia de anomalías congénitasen América Latina y el Caribe: presente y futuro [Systems forsurveillance of birth defects in Latin America and the Caribbean:present and futureSistemas de vigilância de anomalias congênitasna América Latina e Caribe: presente e futuro]. Revistapanamericana de salud publica = Pan American journal of publichealth, 43, e44. https://doi.org/10.26633/RPSP.2019.44

  8. Organización Mundial de la Salud, 63.a Asamblea Mundial de laSalud. Punto 11.7. Defectos congénitos: informe de la secretaria .Ginebra: OMS; 2010. [Acceso el 15 de junio de 2020]. Disponibleen: http://apps.who.int/gb/ebwha/pdf_fi les/WHA63/A63_10-sp.pdf. [Google Scholar]

  9. Naciones Unidas. Transformar nuestro mundo: la Agenda 2030para el Desarrollo Sostenible. Nueva York: NU; 2015. Disponibleen: http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&referer=http://www.un.org/sustainabledevelopment/development-agenda/&Lang=S

  10. Instituto Nacional de Estadística y Geografía (2020) Disponibleen: https://www.inegi.org.mx

  11. Secretaría de Salud (2021) Información epidemiológica. DirecciónGeneral de Epidemiología. Disponible en: https://www.gob.mx/salud/acciones-y-programas/informacion-epidemiologica

  12. Durán P, Liascovich R, Barbero P, Bidondo MP, Groisman B,Serruya S, et al. Sistemas de vigilancia de anomalías congénitas enAmérica Latina y el Caribe: presente y futuro. Rev Panam SaludPublica. 2019;43:e44. https://doi.org/10.26633/RPSP.2019.44




2020     |     www.medigraphic.com